China approves Shanghai Fosun’s unit to run human testing for BioNTech’s COVID-19 vaccine

Shanghai Fosun Pharmaceutical Group said on Friday that its unit has received clinical trial approval from China’s National Medical Products Administration for a COVID-19 vaccine candidate developed …
( read original story …)

---

---